Bone Density Screening
Learn about Bone Density Screening (DEXA Scan, Bone Mineral Density Test) for osteoporosis screening and diagnosis. This resource provides information for healthcare professionals on clinical documentation and medical coding related to low bone density, osteoporosis, and fracture risk assessment. Find details on ICD-10 codes, CPT codes, and best practices for bone density testing and reporting in medical records.
Test measuring bone mineral density to assess fracture risk, particularly for osteoporosis.
Often asymptomatic, but may include back pain, loss of height, or fractures.
Outpatient clinics, radiology departments, and hospitals.
ICD-10 Code Families
Complete code families applicable to Z13.820
When to use each related code
| Description | When to use |
|---|---|
| Checks bone strength, screens for osteoporosis. | Suspected osteoporosis, low bone density risk factors, monitoring treatment. |
| Diagnosed decrease in bone mass, increased fracture risk. | Fragility fractures, abnormal DEXA results, consistent with osteoporosis criteria. |
| Low bone mass, higher than normal fracture risk. | DEXA T-score between -1.0 and -2.5, no fragility fractures, risk factors present. |
Best-practice checklist
- ✓Document Z-score or T-score.
- ✓Specify skeletal site measured (e.g., hip, spine).
- ✓Note indication for bone density testing (e.g., fracture risk assessment).
- ✓Record patient demographics & relevant medical history (e.g., prior fractures).
- ✓Include units of measurement (e.g., g/cm2).
Common pitfalls to avoid
Insufficient documentation to support medical necessity for DEXA scan, leading to denials and compliance issues.
Incorrect Z-code usage for screening vs. diagnostic DEXA, impacting reimbursement and data accuracy.
Missing or inaccurate diagnosis code for a fracture or related condition, affecting risk adjustment and quality reporting.
Best-practice tips
- 01Document Z-codes for risk factors like family history (Z82.4).
- 02Ensure proper ICD-10-CM coding (e.g., M85.80 for osteoporosis).
- 03Specific DEXA scan type/body part improves CDI and HCC coding.
- 04Clear documentation of T-scores and Z-scores for accurate reporting.
- 05Follow USPSTF guidelines for age/risk-based screening frequency.
Step-by-step checklist
- 1
Verify patient age and sex meet criteria (ICD-10 Z13.820)
- 2
Assess fracture risk factors (SNOMED CT 71388002)
- 3
Review prior DEXA results if available (LOINC 48767-8)
- 4
Document rationale for testing and patient consent
Ready-to-paste narrative
Patient presented for bone density screening due to concerns regarding osteoporosis risk. Relevant risk factors discussed included age, family history of osteoporosis, and current medication regimen. A dual-energy x-ray absorptiometry (DEXA) scan, also known as a bone mineral density test, was ordered and performed today to assess bone health and fracture risk. The patient's T-score and Z-score will be documented upon result availability. Preliminary findings, clinical indications, and differential diagnoses for low bone density, including osteopenia and osteoporosis, will be reviewed with the patient upon receipt of the final DEXA scan report. A comprehensive treatment plan, including lifestyle modifications such as calcium and vitamin D supplementation, weight-bearing exercise, and fall prevention strategies, will be discussed if indicated. Pharmacological interventions, such as bisphosphonates or other osteoporosis medications, will be considered based on the final bone density results and FRAX score assessment. Follow-up appointment scheduled to review results and formulate a personalized osteoporosis management plan. ICD-10 code Z13.820, Encounter for screening for osteoporosis, was used for this preventive health service. CPT code 77080, Dual-energy x-ray absorptiometry (DXA), bone density study, axial skeleton (eg, hips, pelvis, spine), was billed for the DEXA scan procedure.
Common questions and answers
What are the most effective bone density screening guidelines for postmenopausal women with no prior fractures, considering risk factors like family history and glucocorticoid use?+
Current guidelines, including those from the National Osteoporosis Foundation (NOF), recommend bone mineral density testing (BMD) with dual-energy X-ray absorptiometry (DEXA scan) for all women age 65 and older regardless of risk factors. For postmenopausal women younger than 65, the decision to pursue osteoporosis screening should be based on individual risk factors such as family history of hip fracture, current glucocorticoid use, low body weight, smoking history, and excessive alcohol consumption. Clinicians should use a validated FRAX (Fracture Risk Assessment Tool) score to estimate 10-year fracture probability and consider initiating BMD testing if the risk is comparable to or exceeds that of a 65-year-old white woman without major risk factors. Explore how integrating FRAX scores into your practice can improve osteoporosis screening decisions. Consider implementing a standardized risk assessment protocol for all postmenopausal women to ensure appropriate and timely bone density screening.
How do I interpret T-scores and Z-scores from a DEXA scan to accurately diagnose osteoporosis and osteopenia, and what follow-up steps are warranted based on the results?+
DEXA scan T-scores compare a patient's bone mineral density (BMD) to the average BMD of a young healthy adult of the same sex. A T-score of -1.0 or above is considered normal. Osteopenia is diagnosed with a T-score between -1.0 and -2.5, while osteoporosis is diagnosed with a T-score of -2.5 or below. Z-scores, on the other hand, compare the patient's BMD to the average BMD of someone their own age, sex, and ethnicity. A significantly low Z-score (typically below -2.0) may suggest a secondary cause of bone loss beyond age-related decline, warranting further investigation. Following diagnosis, appropriate management strategies should be implemented. For patients with osteopenia, lifestyle modifications like increasing calcium and vitamin D intake, weight-bearing exercise, and smoking cessation are recommended. Learn more about the latest recommendations for osteoporosis management based on T-scores and fracture risk. Consider implementing a patient education program on lifestyle modifications for bone health.
Beyond DEXA scans, what other diagnostic tools or imaging modalities can be used to assess bone health and fracture risk in patients, particularly those with contraindications to DEXA?+
While DEXA remains the gold standard for bone density screening, alternative methods like quantitative computed tomography (QCT) and peripheral DEXA (pDEXA) can provide valuable information, especially for patients with contraindications to standard DEXA, like pregnancy or recent contrast studies. QCT measures volumetric BMD at specific sites like the spine and hip and can differentiate trabecular and cortical bone. Peripheral DEXA assesses BMD at peripheral sites such as the wrist, heel, or finger, offering a more portable and less expensive option, although it may not be as accurate as central DEXA for predicting hip fracture risk. Other tools like quantitative ultrasound (QUS) can also provide information about bone quality and fracture risk but are generally considered less sensitive than DEXA. Explore how different imaging modalities can complement DEXA scans in comprehensive bone health assessment. Consider implementing a referral pathway for patients requiring alternative bone density assessment methods.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.